The Board of NeoDynamics has extensive experience from medical technology, pharmaceutical, and financial businesses.

*Independent in relation to NeoDynamics AB (publ), its management, and the principal shareholders.

Ingrid Salén

Independent* chairperson of the Board since 2016.
Education: M.Sc. in Mechanical Engineering.
Work/experience: Scania CV AB - several roles - Global Purchasing between 1995 and 2009. Maquet Critical Care AB - Director of Sourcing and Supplier Management between May 2012 and Mar 2014.
Board memberships: Chairperson of the Board at Garpco AB, Developeration AB, and Vividye AB.
Holds: 895,245 shares via Rentability Sweden AB.

Carina Bolin

Independent* Board member since 2018.
Education: Lawyer (Jur.kand; equiv. to LL.M).
Work/Experience: Approx. 35 years of experience from work as a legal counsel, 30 years of which in internationally operating organisations. Legal consultant in own company since 2020. Previously, general counsel for companies in life science/medical technology (Olink Proteomics AB and Q-Med AB), legal counsel in several other organisations, incl. ABB AB and IP law firm Brann AB.
Board memberships: Previously Chairperson of the Board at, among others, Academicum Utbildning & Bemanning AB, Apoteksammariten AB, and Board member at several corporate subsidiaries.
Holds: 3,903 shares.

Claes Pettersson

Independent* Board member since 2015.
Education: Academic background in mechanical engineering and economics, Linköping University.
Work/experience: More than 40 years experience from driving and developing companies through leadership roles or board memberships in sectors such as Medtech, banking, manufacturing or software.
Board memberships: Chairperson of the board at Energicenter i Öst AB, Något Bra AB and Skälhammar & Månsson Brunnsborrning AB as well as board memer at Onslip holding group.
Holds: 305,973 shares.

Matthew E. Colpoys, Jr.

Board member since 2021.
Education: Degree from Canisius College.
Work/experience: More than 35 years of experience from the Biopharma and Medtech industry with commercial, business development and leadership roles at Genentech, Pharmacia, Neurex, Insmed, and others. Current president at Galileo Consulting, a global biopharmaceutical advisory and consulting company. CEO of NeoDynamics Inc in the USA.
Board memberships: -
Holds: 0 shares.